Drug & Medicine News
Timely news from pharmaceutical companies and health regulators — reviewed and rewritten by our editorial team.
SPONSORED CONTENT
Sponsored headline goes here
One or two sentences describing the sponsor’s message, written by the advertiser and clearly separated from independent editorial content.
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
Responses were deep and durable, with 65% ongoing at clinical cutoff Results support continued evaluation of the investigational RYBREVANT FASPRO regimen in…
-
FDA Expands AI Capabilities and Completes Data Platform Consolidation
FDA announced major steps in its bold initiative to modernize the agency. The agency launched Elsa 4.0, a significant upgrade to the…
-
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without…
-
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain…
-
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently…
-
UK-US trade deal will mean the NHS has to divert billions from other services to pay more for new medicines
Around £45 billion in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under…
-
Cracking open a can of cannabis—America's new pastime (for now)
At Fourth of July barbecues this weekend, Americans are more likely than ever to crack open a can of cannabis rather than…
-
Autism research finds Phelan-McDermid syndrome may affect 1 in 7,300 people: More common than previously thought
New research, led by scientists from the Seaver Autism Center for Research and Treatment at Mount Sinai and published in Autism Research,…
-
Research confirms safety in voluntary assisted dying
New research demonstrates that the Victorian model for oral self-administration of voluntary assisted dying (VAD) medication is safe and effective, providing the…
-
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped…